Latest News and Press Releases

ADMA Biologics Investigated for Securities Fraud Over Alleged Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law

Totaligent (OTCID: TGNT) Targets $273B Medical Tourism Market Via Aetherium Acquisition

ADMA Biologics Inquiry Alert: Investors with Losses after Channel Stuffing Allegations are Urged to Contact BFA Law about its Securities Investigation

The strategic alliance expands existing collaboration and strengthens OTXL’s ability to advance cell and gene therapies for ultra-rare conditions.

ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money

ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered Losses

ADMA Biologics 29% Stock Drop Leads to Securities Fraud Investigation – BFA Law Encourages Investors with Losses to Act

ADMA Biologics Stock Plummeted 29% on News of Channel Stuffing – Investors Notified to Contact BFA Law about its Investigation

ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending Investigation

The FDA is making AI part of the R&D core infrastructure and companies like Totaligent (OTCID: TGNT) are building the “picks-and-shovels” layer of biotech